Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in rheumatoid arthritis patients and relatives from Brazil

Rheumatology

Volumn 49, Issue 8, 2010, Pages 1590-1593

  Goeldner, Isabela ^a   Skare, Thelma L ^b   de Messias Reason, Iara T ^a   Nisihara, Renato M ^a   Silva, Marília B ^b   da Rosa Utiyama, Shirley R ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b University Evangelic Hospital   (Brazil)

Author keywords

Anti cyclic citrullinated peptide antibody; Family; Rheumatoid arthritis

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; IMMUNOGLOBULIN M; RHEUMATOID FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LATEX AGGLUTINATION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELATIVE; RHEUMATOID ARTHRITIS; SCHOOL CHILD; SMOKING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; ARTHRITIS, RHEUMATOID; BRAZIL; CASE-CONTROL STUDIES; CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PEDIGREE; PEPTIDES, CYCLIC; PREDICTIVE VALUE OF TESTS; RHEUMATOID FACTOR; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 77954701093     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq134     Document Type: Article

References (20)

1. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2001;358:903-11.
2. Landewé RB. The benefits of early treatment in rheumatoid arthritis: confounding by indication, and the issue of timing [Editorial]. Arthritis Rheum 2003;48:1-5.
3. Rojas-Villarraga A, Diaz FJ, Calvo-Páramo E et al. Familial disease, the HLA-DRB1 shared epitope and anti-CCP antibodies influence time at appearance of substantial joint damage in rheumatoid arthritis. J Autoimmun 2009; 32:64-9.
4. Utiyama SR, Nass FR, Kotze LM, Nisihara RM, Ambrosio AR, Messias-Reason IT. Serological screening of relatives of celiac disease patients: antiendomysium antibodies, anti-tissue transglutaminase or both? Arq Gastroenterol 2007;44:156-61.
5. Arbuckle MR, McClain MT, Rubertone MV et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526-33.
6. Ioan-Facsinay A, Willemze A, Robinson DB et al. Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease. Arthritis Rheum 2008;58:3000-8.
7. Lee AN, Beck CE, Hall M. Rheumatoid factor and anti-CCP antibodies in rheumatoid arthritis: a review. Clin Lab Sci 2008;21:15-18.
8. Nishimura K, Sugiyama D, Kogata Y et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 2007;146:797-808.
9. Vallbracht I, Rieber J, Oppermann M, Förger F, Siebert U, Helmk K. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann Rheum Dis 2004;63:1079-84.
10. Van Venrooij WJ, van Beers JJ, Pruijn GI. Anti-CCP antibody, a marker for the early detection of rheumatoid arthritis. Ann N Y Acad Sci 2008;1143:268-85.
11. Michou L, Rat AC, Lasbleiz S, Bardin T, Cornélis F. Prevalence and distribution of autoimmune diseases in 368 rheumatoid arthritis families. J Rheumatol 2008;35:790-6.
12. Hemminki K, Li X, Sundquist J, Sundquist K. Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions. Arthritis Rheum 2009;60:661-8.
13. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
14. El-Gabalawy H. The preclinical stages of RA: lessons from human studies and animal models. Best Pract Res Clin Rheumatol 2009;23:49-58.
15. El-Gabalawy H, Robinson DB, Hart D et al. Immunogenetic risk of anti-cyclical citrullinated peptide antibodies in a North American native population with rheumatoid arthritis and their first-degree relatives. J Rheumatol 2009;36:1130-5.
16. Sokka T, Toloza S, Cutolo M et al. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther 2009;11:R7.
17. Van Vollenhoven RF. Sex differences in rheumatoid arthritis: more than meets the eye. BMC Med 2009;7:12.
18. Klareskog L, Stolt P, Lundberg K et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006;54:38-46.
19. Lee DM, Phillips R, Hagan EM, Chibnik LB, Costenbader KH, Schur PH. Quantifying anti-CCP titer: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis. Ann Rheum Dis 2009;68:201-8.
20. Harney S, Wordsworth BP. Genetic epidemiology of rheumatoid arthritis. Tissue Antigens 2002;60:465-73.